Impel NeuroPharma Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trader Talk Trading Halts

Impel NeuroPharma Inc. (IMPL) Launches 3M Share Proposed OfferingSeptember 7, 2021 4:01 PM Impel Neuropharma (IMPL) PT Raised to $55 at Cowen on FDA ApprovalSeptember 3, 2021 10:57 AM Impel NeuroPharma Inc. (IMPL) Announces FDA Approval of TRUDHESA for MigraineSeptember 3, 2021 8:52 AM Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of MigraineSeptember 3, 2021 8:51 AM Impel NeuroPharma Inc. (IMPL) halted, news pendingSeptember 3, 2021 8:25 AM